Bicarbonate

Bicarbonate

SCHEMBL437197

O=C([O-])[O-].O=C([O-])[O-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.46
CA1 P00915 2/20 0.46
FAHD1 Q6P587 1/20 0.46
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
LDHA P00338 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL9576852 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL26654550 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL14243879 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL614488 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL27986975 0.94
Bicarbonate SCHEMBL6580035 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL28193174 0.94
Bicarbonate SCHEMBL1679609 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL10408290 0.94 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL7518275 0.94 CA4 (0.50) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630578-B2 Methods for the production of calcium, magnesium, and zinc salts of sugar acids DFI USA, LLC (US) 2026-05-19 US claimed
EP-4418865-B1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2025-12-10 EP claimed
US-20250228997-A1 BONE REGENERATIVE AGENT AND METHOD OF USING SAME JFE MINERAL COMPANY, LTD. (JP) 2025-07-17 US claimed
US-20250170034-A1 COMPOSITION FOR TOOTH WHITENING OR IMPROVING DENTIN HYPERSENSITIVITY COMPRISING POLYPHOSPHATE LG H & H CO., LTD. (KR) 2025-05-29 US claimed
CN-119925179-A Composition for tooth whitening or improving dentin hypersensitivity comprising polyphosphate 株式会社LG生活健康 2025-05-06 CN claimed
CN-119774741-A Sewage purification equipment and purification method for preparing basic zinc carbonate 福建冠鑫新材料有限公司 2025-04-08 CN claimed
CN-119632890-A Berry composition for scalp care and preparation method and application thereof 拉芳家化股份有限公司 2025-03-18 CN claimed
CN-119564519-A Toothpaste composition for inhibiting dental plaque and improving gingivitis, finished toothpaste and preparation method thereof 马应龙大健康有限公司 2025-03-07 CN claimed
EP-4005636-B1 BONE REGENERATIVE AGENT AND METHOD OF USING SAME JFE MINERAL CO LTD (JP) 2025-01-08 EP claimed
CN-119112749-A Anti-aging repairing cosmetic composition, and preparation method and application thereof 马应龙大健康有限公司 2024-12-13 CN claimed
CN-1353146-A Process for preparing composite nano material and its application in modifying polyester QILU CHEMICAL FIBER GROUP CO L (CN) 2002-06-12 CN claimed
US-6107534-A USING THE IMPROVED ZEOLITE CATALYST IN THE CONVERSION OF HYDROCARBONS, PREFERABLY NON-AROMATIC HYDROCARBONS, TO LOWER OLEFINS (SUCH AS ETHYLENE AND PROPYLENE) AND AROMATIC HYDROCARBONS (SUCH AS BENZENE, TOLUENE, AND XYLENE) PHILLIPS PETROLEUM COMPANY (US) 2000-08-22 US claimed
US-6084142-A HYDROFINING TO FORM LOWER OLEFINS AND AROMATICS USING ZINC-INCORPORATED AND STEAM TREATED ZEOLITE ZSM-5; NONCOKING PHILLIPS PETROLEUM COMPANY (US) 2000-07-04 US claimed
US-6037294-A ACID-TREATING ZEOLITE, ION-EXCHANGING WITH ZINC AND AT LEAST ONE GROUP 6B METAL, THEN STEAM TREATING PHILLIPS PETROLEUM COMPANY (US) 2000-03-14 US claimed
US-5981417-A TREATING ZEOLITE WITH AN ACID TO FORM ACID-TREATED ZEOLITE, STEAM TREATING ABOVE ZEOLITE, IMPREGNATING BORON COMPONENT AND ZINC COMPONENT WITH STEAM AND ACID TREATED ZEOLITE, AND STEAM TREATING INCORPORATED ZEOLITE PHILLIPS PETROLEUM COMPANY (US) 1999-11-09 US claimed
US-5945371-A ZINC AND MOLYBDENUM MIXED OXIDE HYDRODEALKYLATION CATALYST PHILLIPS PETROLEUM COMPANY (US) 1999-08-31 US claimed
US-5789642-A HYDROREFINING CATALYSTS OF ALUMINA WITH MOLYBDENUM AND ZINC, REMOVAL OF EXCESS LIQUID AND DRYING AND ROASTING PHILLIPS PETROLEUM COMPANY (US) 1998-08-04 US claimed
US-4720380-A Hydrogen-phosphide releasing compositions and processes for their production and use DR. WERNER FREYBERG CHEMISCHE FEBRIK DELITIA NASCHF. (DE) 1988-01-19 US claimed
EP-0109635-B1 PROCESS FOR PURIFYING GASES CONTAINING CO AND/OR CO2 BASF Aktiengesellschaft (DE) 1986-03-19 EP claimed
US-4503032-A ALUMINUM PHOSPHIDE, AMMONIA SOURCE, ZINC OR ZINC COMPOUND DR. WERNER FREYBERG CHEMISCHE FABRIK DELITIA NACHF (DE) 1985-03-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630578-B2 Methods for the production of calcium, magnesium, and zinc salts of sugar acids SLC5A6, SOD1, MGAM CA4 85/4885CA1 64/4885FAHD1 1519/4885
US-20250170034-A1 COMPOSITION FOR TOOTH WHITENING OR IMPROVING DENTIN HYPERSENSITIVITY COMPRISING POLYPHOSPHATE KCNN3, KCNN1, POLR1C CA4 1497/4885CA1 1612/4885FAHD1 2344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.